1 |
1639325-43-1 |
- |
- |
- |
- |
254 1件: 254 💬 |
2 |
5-probe cocktail |
- |
- |
- |
- |
254 1件: 254 💬 |
3 |
[mt-7117] |
- |
- |
- |
- |
254 1件: 254 💬 |
4 |
[nle4,d-phe7]-a-melanocyte stimulating hormone or ndp-a-msh |
- |
- |
- |
- |
254 1件: 254 💬 |
5 |
A novel synthetic, orally-administered, non-peptide small molecule, which acts as |
- |
- |
- |
- |
254 1件: 254 💬 |
6 |
Afamelanotide |
Afamelanotide |
1件: D10511 D10511 💬 |
- |
- |
254 1件: 254 💬 |
7 |
Afamelanotide implant |
Afamelanotide |
1件: D10511 D10511 💬 |
- |
- |
254 1件: 254 💬 |
8 |
Aln-60519 |
- |
- |
- |
- |
254 1件: 254 💬 |
9 |
Aln-as1 |
- |
- |
- |
- |
254 1件: 254 💬 |
10 |
Cas # in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 1件: 254 💬 |
11 |
Cas# in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 1件: 254 💬 |
12 |
Chlorpromazine |
Chlorpromazine |
4件: D00270 D00270, D00789 D00789, D03274 D03274, D04034 D04034 💬 |
ADRA2A 13件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
254 1件: 254 💬 |
13 |
Chlorpromazine hydrochloride |
Chlorpromazine |
4件: D00270 D00270, D00789 D00789, D03274 D03274, D04034 D04034 💬 |
ADRA2A 13件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
254 1件: 254 💬 |
14 |
Colestipol |
Colestipol |
2件: D02113 D02113, D07771 D07771 💬 |
- |
- |
254 1件: 254 💬 |
15 |
Colestyramine |
Cholestyramine |
- |
- |
- |
254 1件: 254 💬 |
16 |
Concentration unit: mg milligram(s) |
- |
- |
- |
- |
254 1件: 254 💬 |
17 |
Cuv1647 |
- |
- |
- |
- |
254 1件: 254 💬 |
18 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
19 |
Cysteine hydrochloride |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
254 1件: 254 💬 |
20 |
Deferasirox |
Deferasirox |
1件: D03669 D03669 💬 |
- |
- |
254 3件: 254, 284, 286 💬 |
21 |
Dersimelagon |
- |
- |
- |
- |
051 2件: 51, 254 💬 |
22 |
Exjade |
- |
- |
- |
- |
254 3件: 254, 284, 286 💬 |
23 |
Givosiran |
Givosiran |
1件: D11702 D11702 💬 |
ALAS1 1件: ALAS1 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |
24 |
Givosiran (aln-as1) |
Givosiran |
1件: D11702 D11702 💬 |
ALAS1 1件: ALAS1 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |
25 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
26 |
Harvoni |
- |
- |
- |
- |
254 1件: 254 💬 |
27 |
Heme arginate |
- |
- |
- |
- |
254 1件: 254 💬 |
28 |
Hemin |
Hemin |
1件: D10003 D10003 💬 |
ALAS1 2件: ALAS1, ALAS2 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |
29 |
Hemin for injection |
Hemin |
1件: D10003 D10003 💬 |
ALAS1 2件: ALAS1, ALAS2 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |
30 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
31 |
Iron |
Iron |
- |
- |
- |
018 5件: 18, 96, 97, 254, 284 💬 |
32 |
Isoniazid |
Isoniazid |
3件: D00346 D00346, D01501 D01501, D02002 D02002 💬 |
- |
- |
254 1件: 254 💬 |
33 |
Luteinizing hormone |
Luteinizing hormone |
- |
- |
- |
254 1件: 254 💬 |
34 |
Luteinizing hormone-releasing factor |
Luteinizing hormone |
- |
- |
- |
254 1件: 254 💬 |
35 |
Mt-7117 |
- |
- |
- |
- |
051 2件: 51, 254 💬 |
36 |
Mt-7117 high dose |
- |
- |
- |
- |
254 1件: 254 💬 |
37 |
Mt-7117 low dose |
- |
- |
- |
- |
254 1件: 254 💬 |
38 |
Nle4-d-phe7-alpha-msh |
- |
- |
- |
- |
254 1件: 254 💬 |
39 |
Oral iron |
Iron |
- |
- |
- |
254 1件: 254 💬 |
40 |
Other: glucose |
Dextrose, unspecified form |
- |
- |
- |
254 1件: 254 💬 |
41 |
Panhematin |
- |
- |
- |
- |
254 1件: 254 💬 |
42 |
Porphobilinogen |
Porphobilinogen |
- |
- |
- |
254 1件: 254 💬 |
43 |
Procedure: phlebotomy |
- |
- |
- |
- |
254 1件: 254 💬 |
44 |
Questran |
- |
- |
- |
- |
093 3件: 93, 254, 297 💬 |
45 |
Recombinant human porphobilinogen deaminase (porphozym) |
Porphobilinogen |
- |
- |
- |
254 1件: 254 💬 |
46 |
Scenesse |
- |
- |
- |
- |
161 2件: 161, 254 💬 |
47 |
Sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
062 3件: 62, 234, 254 💬 |
48 |
Tin mesoporphyrin |
Stannsoporfin |
1件: D05922 D05922 💬 |
HMOX1 2件: HMOX1, HMOX2 💬 |
Ferroptosis 9件: Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |